METHAMPHETAMINE |
METAMFETAMINE |
J6.362B |
NSC-25115 |
D-N-METHYLAMPHETAMINE |
METANFETAMINA |
MÉTAMFÉTAMINE |
DESOXYEPHEDRINE |
(S)-N,ALPHA-DIMETHYLBENZENEETHANAMINE |
D-DEOXYEPHEDRINE |
(ALPHAS)-N,ALPHA-DIMETHYLBENZENEETHANAMINE |
(ΑS)-N,Α-DIMETHYLBENZENEETHANAMINE |
METHAMPHETAMINE, METHYLAMPHETAMINE |
(+)-(S)-P-Α-DIMETHYLPHENETHYLAMINE |
D-DESOXYEPHEDRINE |
METHYL-Β-PHENYLISOPROPYLAMINE |
N-METHYLAMPHETAMINE |
D-PHENYLISOPROPYLMETHYLAMINE |
METHYL-BETA-PHENYLISOPROPYLAMINE |
METAMFETAMINUM |
(+)-(S)-N-ALPHA-DIMETHYLPHENETHYLAMINE |
METHAMPHETAMINUM |
S-METHAMPHETAMINE |
METH |
D-1-PHENYL-2-METHYLAMINOPROPANE |
(S)-N,Α-DIMETHYLBENZENEETHANAMINE |
METHYLAMPHETAMINE |
DEXTROMETHAMPHETAMINE |
chemidplus:537-46-2 |
pubchem.compound:10836 |
chembl:CHEMBL1201201 |
rxcui:6816 |
drugbank:01577 |
Year of Approval | approved before 1982 |
Drug Class | central nervous system stimulants |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | neuroprotectant |
inhibitor (inhibitory) |
Trial Name | low dose intravenous methamphetamine |
Novel drug target | Established target |
inhibitor (inhibitory) |
Trial Name | low dose intravenous methamphetamine |
Novel drug target | Established target |
negative modulator (inhibitory) |
Trial Name | low dose intravenous methamphetamine |
Novel drug target | Established target |
negative modulator (inhibitory) |
Trial Name | low dose intravenous methamphetamine |
Novel drug target | Established target |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | low dose intravenous methamphetamine |
agonist (activating) |
Trial Name | low dose intravenous methamphetamine |
Novel drug target | Established target |
agonist (activating) |
Trial Name | low dose intravenous methamphetamine |
Novel drug target | Established target |
agonist (activating) |
Trial Name | low dose intravenous methamphetamine |
Novel drug target | Established target |
METHAMPHETAMINE | Primary Drug Name |
Drug Class | central nervous system stimulants |
Year of Approval | approved before 1982 |
Drug Indications | neuroprotectant |
Drug Class | Small Molecule |
FDA Approval | approved |
D0P6UB | TTD Drug ID |